ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001213900-22-048196
| Metric | Q2 2022 | Q2 2021 |
|---|---|---|
| Net Income | -$393.64K | -$1.90K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end
